Introduction

A conversation between MIT Technology Review and Stanford bioengineering student Samuel King has sparked fresh discussion about the capabilities of generative artificial intelligence in biology. King's work explores whether AI can propose viable genetic structures for microscopic viruses, pushing the boundaries of synthetic biology.

What Happened

In 2025, Samuel King used a generative AI model to propose genetic blueprints for microscopic viruses. The experiment demonstrated that AI can outline viral sequences, though the work stops short of creating functional, replicated life. King discussed the process and his recognition as one of MIT Technology Review's Innovators Under 35 in an interview with senior AI reporter James O'Donnell.

Why This Matters

The experiment highlights a significant step in applying AI to biological design, raising questions about the future of AI-generated life and the ethical boundaries of synthetic biology. While the blueprints do not yet result in viable organisms, they signal a shift toward powerful computational tools in life sciences, prompting careful consideration of safety, regulation, and the definition of life itself.

Key Takeaways

  • Samuel King used generative AI to propose genetic blueprints for microscopic viruses in 2025.
  • The work was featured in MIT Technology Review's Roundtables series and recognized as part of the Innovators Under 35 program.
  • AI can outline viral genetic sequences, but the research does not yet constitute creating functional, replicated life.
  • The experiment opens dialogue on the role of artificial intelligence in synthetic biology and its future implications.

Conclusion

As AI tools become more capable of interacting with biological data, conversations like this one help frame the opportunities and responsibilities that come with such power. King's work invites both excitement and caution as the line between computational design and biological creation continues to evolve.